Based on this observation, we examined the expression of IGFBP-5 in a mouse model of 2,4-dinitrochlorobenzene (DNCB)-induced AD-like pathology and found that the mRNA expression of IGFBP-5 was decreased in AD mice compared to normal mice (Figure 4B). This evidence concerns the gene IGFBP5 and Alzheimer disease.